Nektar Therapeutics (NKTR) — Cash Flow Reinvestment Rate
Nektar Therapeutics (NKTR) has a Cash Flow Reinvestment Rate of 0.93x as of June 2018, reinvesting $897.05 Million (capex $2.75 Million plus investments $-894.30 Million) from operating cash flow of $959.64 Million. Explore how much does Nektar Therapeutics reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nektar Therapeutics Cash Flow Reinvestment Rate (1997–2018)
Historical reinvestment intensity for Nektar Therapeutics across 4 annual periods. Also explore Nektar Therapeutics assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nektar Therapeutics (1997–2018)
Year-by-year capital reinvestment analysis for Nektar Therapeutics. For live market cap and broader valuation context, see Nektar Therapeutics stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2018 | 1.93x | $1.38 Billion | $718.21 Million | $14.24 Million | ▲ +269.5% |
| 2009 | 0.52x | $20.70 Million | $39.74 Million | $20.70 Million | ▲ +132.4% |
| 2007 | 0.22x | $32.80 Million | $146.30 Million | $32.80 Million | ▼ -93.5% |
| 1997 | 3.47x | $17.26 Million | $4.98 Million | $17.26 Million | — |